alpha-2-macroglobulin
| UniProt | Protein Name |
|---|---|
| P01023 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| luteinization | ||
| negative regulation of complement activation, lectin pathway | ||
| acute inflammatory response to antigenic stimulus | ||
| acute-phase response | ||
| response to nutrient |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular exosome | ||
| blood microparticle |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protease binding | ||
| protease binding | ||
| endopeptidase inhibitor activity | ||
| endopeptidase inhibitor activity | ||
| serine-type endopeptidase inhibitor activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0080600 | COVID-19 | |
| DOID:10652 | Alzheimer's disease | |
| DOID:13208 | background diabetic retinopathy | |
| DOID:14330 | Parkinson's disease | |
| DOID:2320 | obstructive lung disease | |
| DOID:2377 | multiple sclerosis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026